Literature DB >> 17566947

Intrauterine balloon tamponade in the management of postpartum hemorrhage.

Victor Dabelea1, Peter M Schultze, Robert S McDuffie.   

Abstract

This article reviews our experience with the use of intrauterine tamponade with balloon catheters in the management of severe postpartum hemorrhage. This is a case series report of 23 patients with postpartum hemorrhage unresponsive to medical therapy managed with intrauterine balloon tamponade. We identified these patients by International Classification of Diseases (ICD-9) codes and by reviewing labor and delivery logs. Balloon tamponade was attempted in 23 patients. When properly placed, catheters controlled postpartum hemorrhage in 18 of 20 cases (90%). In two cases, hysterectomy was required despite successful placement of the catheter. For hemorrhage due to uterine atony, our success rate was 100% (11/11 cases). In three cases, technical difficulties led to placement failure. For bleeding due to retained placenta, our success rate was 80% (4/5; failure with placenta percreta). Vaginal bleeding was stopped with the catheter in two of three cases of amniotic fluid embolus and in one case after dilation and curettage for postpartum septic shock. Thus balloon tamponade is an effective adjunct in the treatment of severe postpartum hemorrhage, especially when due to uterine atony when medical therapy fails.

Entities:  

Mesh:

Year:  2007        PMID: 17566947     DOI: 10.1055/s-2007-984402

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  15 in total

1.  Cesarean scar dehiscence associated with intrauterine balloon tamponade placement after a second trimester dilation and evacuation.

Authors:  Reni Soon; Tod Aeby; Bliss Kaneshiro
Journal:  Hawaii Med J       Date:  2011-07

Review 2.  Role of Balloon Tamponade as a Therapeutic Non-Surgical Tool in Controlling Obstetric and Gynecological Hemorrhage in Low-Resource Countries.

Authors:  C N Purandare; Amala Khopkar Nazareth; Gillian Ryan; Nikhil C Purandare
Journal:  J Obstet Gynaecol India       Date:  2022-06-01

3.  Uterine rupture complicating sequential curettage and Bakri balloon tamponade to control secondary PPH.

Authors:  Olukunle Adegboye Ajayi; Manjusha Sant; Sunday Ikhena; Abdumalik Bako
Journal:  BMJ Case Rep       Date:  2013-02-06

4.  Factors associated with peripartum hysterectomy.

Authors:  Clara Bodelon; Antonio Bernabe-Ortiz; Melissa A Schiff; Susan D Reed
Journal:  Obstet Gynecol       Date:  2009-07       Impact factor: 7.661

5.  Management of intractable postpartum haemorrhage in a tertiary center: A 5-year experience.

Authors:  Hüseyin Cengiz; Levent Yaşar; Murat Ekin; Cihan Kaya; Sema Karakaş
Journal:  Niger Med J       Date:  2012-04

6.  Evaluation of compliance and outcomes of a management protocol for massive postpartum hemorrhage at a tertiary care hospital in Pakistan.

Authors:  Lumaan Sheikh; Nida Najmi; Umair Khalid; Taimur Saleem
Journal:  BMC Pregnancy Childbirth       Date:  2011-04-13       Impact factor: 3.007

7.  Double-balloon tamponade in the management of postpartum hemorrhage: a case series.

Authors:  Salih Burçin Kavak; Ebru Çelik Kavak; Ismail Demirel; Raşit Ilhan
Journal:  Ther Clin Risk Manag       Date:  2014-08-02       Impact factor: 2.423

8.  Uterine balloon tamponade in combination with topical administration of tranexamic Acid for management of postpartum hemorrhage.

Authors:  Masato Kinugasa; Hanako Tamai; Mayu Miyake; Takashi Shimizu
Journal:  Case Rep Obstet Gynecol       Date:  2015-03-12

9.  A novel tamponade agent for management of post partum hemorrhage: adaptation of the Xstat mini-sponge applicator for obstetric use.

Authors:  Maria I Rodriguez; Jeffrey T Jensen; Kenton Gregory; Mary Bullard; Paul Longo; Jerry Heidel; Alison Edelman
Journal:  BMC Pregnancy Childbirth       Date:  2017-06-13       Impact factor: 3.007

10.  Efficacy of Intrauterine Bakri Balloon Tamponade in Cesarean Section for Placenta Previa Patients.

Authors:  Hee Young Cho; Yong Won Park; Young Han Kim; Inkyung Jung; Ja-Young Kwon
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.